PillRx only · Tablet, Extended Release · Oral
Diltiazem Hydrochloride
Brands: Cardizem La · Matzim La · Diltiazem Hydrochloride
5 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US29 NDCs
5 active makers
5 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers5 labelers
Packages58
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 34 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.663
Latest avg · Jun 17, 2026
-1%
Since Dec 17, 2025
5
Active US suppliers
41%
Top-2 supplier share*
Who makes it5 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Bausch Health US, LLC | unknown | 12 | SUPPLYING |
| ScieGen Pharmaceuticals, Inc. | unknown | 12 | SUPPLYING |
| Cipla USA Inc. | unknown | 12 | SUPPLYING |
| Slate Run Pharmaceuticals, LLC | unknown | 12 | SUPPLYING |
| Actavis Pharma, Inc. | unknown | 10 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.